Company intelligence
Cyprotex
The ADME-Tox Specialists
Research Services
Macclesfield, GB
203 employees
Founded 1999
1 public signals
About Cyprotex
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology
Verified activity
Signals from Cyprotex
1 published signal